Diabetic Live

The Lack of Sunshine May Increase Risk for Diabetes: If you’ve reached middle age and are looking for a common dietary supplement that can be taken to help reduce the risk of both cardiovascular disease and Type 2 diabetes you might look no further than Vitamin D. For an effective dose of the vitamin you might just try spending more time outdoors.

According to research at the Warwick Medical School at Warwick University in the UK individuals could reduce their “chances of developing heart disease or diabetes by 43%” when sufficient doses of vitamin D were accessed.

The Warwick study concentrated on, “Cardiometabolic disorders include cardiovascular disease, type 2 diabetes mellitus and metabolic syndrome.”

A press release from Warwick indicates that vitamin D is “a fat-soluble vitamin that is naturally present in some foods and is also produced when ultraviolet rays from sunlight strike the skin and trigger vitamin D synthesis. Fish such as salmon, tuna and mackerel are good sources of vitamin D, and it is also available as a dietary supplement.”

The scope of the research is significant in that there was no singular study. Instead researchers compiled data from 28 separate studies that included nearly 100,000 patients. These patients represent both genders and multiple ethnicities. The studies were conducted over a nearly 20-year period in multiple countries including the U.K., the U.S., and India.

According to the release, “The studies revealed a significant association between high levels of vitamin D and a decreased risk of developing cardiovascular disease (33% compared to low levels of vitamin D), type 2 diabetes (55% reduction) and metabolic syndrome (51% reduction).”

Researcher Dr Oscar Franco said, “We found that high levels of vitamin D among middle age and elderly populations are associated with a substantial decrease in cardiovascular disease, type 2 diabetes and metabolic syndrome.

“Targeting vitamin D deficiency in adult populations could potentially slow the current epidemics of cardiometabolic disorders.”

WebMD defined vitamin D as a supplement that promotes, “the proper use of calcium and phosphorus, thereby producing growth, together with proper bone and tooth formation, in young children; the sulfate, a water-soluble conjugate, is found in the aqueous phase of human milk.”

While we understand this as a benefit in youth and as we age it can be easy to forget the benefits of vitamin D in between. This research suggests it is beneficial to keep the vitamin in mind.

WebMD suggests that the most affordable and easily accessible form of vitamin D is simply in spending more time enjoying the outdoors. Your body absorbs vitamin D via the sun storing it much like a rechargeable battery. WebMD suggests, “Exposure of the hands, face, arms, and legs to sunlight two to three times a week for about one-fourth of the time it would take to develop a mild sunburn will cause the skin to produce enough vitamin D.”

Because we tend to spend so much time indoors we are a world suffering from vitamin D deficiency. WebMD elaborates, “Vitamin D deficiency is more common than you might expect. People who don’t get enough sun, especially people living in Canada and the northern half of the US, are especially at risk. Vitamin D deficiency also occurs even in sunny climates, possibly because people are staying indoors more, covering up when outside, or using sunscreens consistently these days to reduce skin cancer risk.”

This trait is also seen as people age and determine to spend more time indoors. The answer is either more time in the sunshine or the use of a vitamin D supplement. Good health may depend more on enjoying sunshine than you imagined.

Introducing the Monthly Diabetes Test: In an effort to manage the costs of healthcare in a more efficient manner one medical company is touting the benefits of a once monthly test that has now officially received a patent.

According to a company press release published a year ago, “The Epinex G1A™ Rapid Diabetes Monitoring Index Test is a revolutionary monthly rapid test that uses glycated albumin to measure how much damage has been done to the body by excess sugar. The Epinex G1A™ test will be a significant asset to help keep costs down by introducing a monthly testing paradigm that has been proven effective. This test could allow doctors to take action sooner than current diabetes testing methods, reducing the severity and cost of diabetes and its complications, which include blindness, kidney failure and cardiac disease.”

This information was published in response to President Obama’s initial suggestion that health care needed a major overhaul. At that time Epinex CEO, Asad Zaidi said, “With our current financial crisis, Epinex is working on a product that will help save our already over-burdened healthcare system billions of dollars, while helping diabetics manage their disease more effectively.”

Almost a year to the day since Epinex introduced their G1A™ Rapid Diabetes Monitoring Index Test another report surfaces. “The United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1A™ Rapid Diabetes Monitoring Index Test. The patent (US7659107B2) is for the first ever rapid glycated albumin test and instrument, which could redefine the way diabetes is monitored for over 250 million diabetics worldwide.”

The Epinex originated press release states that, “Albumin is an ideal monthly marker as it is replaced in the body every 2-3 weeks. Using only a pinprick of blood, the test will simultaneously and rapidly measure glycated albumin and total albumin. Researchers at the Wake Forest University School of Medicine have described glycated albumin as a ‘more robust’ and ‘more accurate’ indicator of long-term glycemic control.”

Albumin is described as, “Any of numerous simple heat-coagulable water-soluble proteins that occur in blood plasma,” by Miriam-Webster Medical.

Epinex describes the standard process for testing, “Diabetics currently monitor themselves with multiple daily blood glucose tests, and HbA1c testing every 4-6 months. Scientific studies have demonstrated that current monitoring methods for type 2 diabetics (95% of all diabetics), are ineffective due to low compliance rates, physiological interference with accuracy, and delayed time frames for therapeutic interventions.”

Zaidi suggests, “Doctors will no longer have to wait 4-6 months to see if treatments are working. “The G1A™ test will allow doctors and patients to adjust their therapeutic and lifestyle interventions on a monthly basis instead.”

The company further indicates, “Several U.S. clinical studies have demonstrated that monthly diabetes management is effective in reducing costs and improving outcomes. Diabetes currently costs the U.S. over $113 billion annually, and costs are projected to triple over the next 25 years. Monthly G1A™ testing has the potential to bring about substantial cost reductions in diabetes care, fewer patient complications, and improved quality of life for over 250 million diabetics worldwide.”

One year ago U.S. President Obama said, “Crushing health care costs…drag down our economy, bankrupt our families, and represent the fastest-growing part of our budget.” Epinex contends their device can play a role in reducing costs and improving the potential of greater diagnostics in patients with diabetes.

Why Prediabetes Isn’t Taken Seriously: Medical staff members suggest that there may be a huge prediabetic population in the United States. Simple steps are offered to these individuals, yet it seems the end result is a failure to acknowledge the condition and to make lifestyle alterations that could prevent diabetes.

According to WebMD, “A new study shows nearly 30% of all adults in the U.S. have prediabetes, yet more than 90% aren’t aware of it. Moreover, only about half of people with prediabetes are taking any steps to reduce their risk, like losing weight or exercising more.”

A diagnosis of prediabetes is a clarion call that asks the patient to turn from the habits that may be allowing diabetic-like symptoms to emerge. Yet for many patients it is simply a diagnosis they feel comfortable ignoring. The reasons may be unclear, but the study does consider some possible reasons, “The results showed only 7.3% said they had been told by a health care provider that they had prediabetes. Less than half (48%) with prediabetes had been tested for diabetes or high blood sugar in the past three years.

“Researchers found adults with prediabetes were more likely to be male, older, and have lower educational status than those without the condition. They were also more likely to have an immediate family member with diabetes.

“When asked if they had taken one of the following three diabetes prevention measures in the last 12 months, only about half said yes,” said the WebMD report.

I think one of the psychological risk factors in not dealing with a diagnosis of prediabetes is denial. If a person doesn’t feel sick they may assume there really is nothing wrong and certainly nothing worth worrying about.

You’ll notice in the above quote that many prediabetics who do nothing to alter their lifestyle actually had other family members with diabetes. These individuals may fall into one of two arenas of thought. The first may be that there is no way to avoid the disease so why try. The other thought suggests that perhaps the individual can dodge a bullet and be the one to avoid the disease. This mentality hinges on the idea of ‘what you don’t know won’t hurt you.’ In the end these individuals will be the ones who do not return for follow-up doctor visits and consider their lack of full diagnosis to indicate they don’t have diabetes.

What you may find interesting is that for those patients who were told they absolutely needed to make lifestyle changes because the doctor was up front about the condition and didn’t hold back the end result in most cases was that the individual was more serious about losing weight and adding exercise to their daily routine.

It is believed that the incidence of diabetes, and by extension prediabetes, may double in the next ten years. This is reason enough for primary care physicians to be very clear when discussing what prediabetes is and what it can lead to. Suggestions should become recommendations and educational programs might need more development in the arena of psychological responses to the news.

It can be easy to disregard the advice of a physician, but in the case of prediabetes the ones you hurt have names. I’m not just talking about your partner and or children, but also you. If you knew someone was going to try to break into your house today you would do whatever you could to stop it. Why isn’t the same concern given to prediabetes. You can replace your material possessions – can you replace your own life?

American Idol and Diabetes: Diabetic news has a decidedly American Idol influence this week with news both stateside as well as from earthquake ravaged Chile.

On February 27th an 8.8 magnitude earthquake struck the South American country of Chile. Amazingly fewer than 1,000 people were reported dead, but many others were stranded including former American Idol contestant Elliott Yamin. Using the social networking tool, Twitter, Yamin sent tweets to his followers telling of the devastation he saw and the people he encountered.

It didn’t take long for Yamin to realize he had his own crisis developing. He tried not to overplay the potential problem, but his plight did become newsworthy. Yamin is a type 1 diabetic and he had only packed enough insulin to last through March 1st (when he expected to be back home). It became clear that outbound flights were not going to be happening anytime soon because relief efforts meant more than usual inbound air traffic. In essence Yamin’s only way out of Chile did no coincide with his need for diabetic medical supplies.

One of Yamin’s tweets read, “I thought this was the end of my life.” As of the 3rd of March Yamin was still in Chile, but due to the assistance of the U.S. Embassy and the manufacturer of his insulin he was able to receive the required medication. He has also ventured to the city of Santiago where he has access to improved medical assistance. It is expected that Yamin will be back in the United States by the time this article is read.

Meanwhile, for the first time in American Idol (AI) history the order of a telecast was altered because of a contestant struggling with diabetes. Idol hopeful Crystal Bowersox was hospitalized as a result of diabetes complications. AI producers made the decision to reverse performance schedules to allow the possibility that Bowersox could still perform. The men performed Tuesday, March 2nd and the women performed the next night.

Bowersox was the first to perform and she seemed fully in control of herself and her performance as she tackled a Credence Clearwater Revival classic.

When Bowersox made no mention of her medical difficulties the American Idol judges took note and praised her for managing such a difficult ordeal without trying to use the instance as a means of enlisting a sympathy vote. Virtually all the judges spoke of her illness and then glowingly about her performance. Ellen DeGeneres went so far as to say the competition needed her.

Bowersox seems intent on encouraging votes in her direction based entirely on her ability as a singer and not because of the disease she lives with. Her performances seem to indicate she is a fan favorite this season.

Yamin and Bowersox are not the only individuals attached to the program to live with diabetes. Judge Randy Jackson was diagnosed with Type 2 diabetes and responded by undergoing a gastric bypass surgery. Jackson is quoted as saying, “It’s like the largest wake up call in your life.” He’s written a book about his experience that was just released through Penguin books.

In 2006 Yamin shared the stage with another Idol hopeful, Kevin Corvais. Both men struggled with Type 1 diabetes.

Perhaps the best news is that both types of diabetes are represented in emerging stories surrounding American Idol. In all cases the individuals involved continue to work at making appropriate choices and controlling their glucose levels. They are determined to not allow the disease to stop them from reaching their goals.

Are Glucose Guidelines Too Strict: There is a radical new idea being discussed in diabetes care. If you read articles here long enough you will find experts that advocate very strict control of blood glucose. Some medical practitioners are now saying it may be time to lighten up a bit on treatment options.

For this report we are relying heavily on a self-penned article by Dr. John Morley in the stltoday.com website. Morley begins by stating, “As an endocrinologist, I have spent more than 30 years trying to lower the sugar levels in diabetics to a normal level. As a diabetic, I have tried to keep my fasting glucose level below 100 mg/dl (milligrams per deciliter) and my hemoglobin A1C (or glycated hemoglobin level) below 6 percent.”

It should be noted that as a diabetic Morley has a vested interest in keeping his own glucose levels under control, yet it seems he struggles with new information, “Three studies conducted during the past couple of years are causing me to rethink my approach to treating diabetes.

“The most dramatic was published this year. Craig Currie and his Cardiff University colleagues examined two groups of more than 20,000 patients in the United Kingdom who were being treated for diabetes. Members of both groups were at least 50 years old. The researchers found that those who were least likely to die had a hemoglobin A1C of 7.5 percent. This is higher than the American Diabetes Association’s recommended hemoglobin A1C level of 7 percent or lower. Those who took insulin, researchers said, had worse outcomes,” said Morley.

In scientific times past there were instances where beliefs were challenged with new information and resulting changes provided improved health care, but does this new information really mean A1C levels no longer matter? Morley continues, “The finding has created a major conundrum for those of us who are diabetic or treat people with diabetes. Rather than trying to reduce the glycated hemoglobin level to close to normal, we should try to keep a patient’s HbA1C in the range of 7 percent to 8 percent. Further support for this strategy comes from studies in older people that suggest patients with HbA1C levels below 7 percent are more likely to fall.

“The reasons for these findings are uncertain. Possibly tight control of glycated hemoglobin levels leads to a condition called hypoglycemia, which occurs when blood sugar levels dip too low.”

Morley then discussed the potential for new diabetic drugs to interfere with normal heart health or provide accumulated fat that can clog arteries. It almost seems as if Morley may be considering the potential of returning to a more simplified approach to managed care.

Morley concludes by asking and answering his own question, “So how will I treat diabetes? Of the medicines for diabetes, the drug that has clearly been shown to decrease death is metformin. The bottom line: I’ll suggest my patients who have type 2 diabetes use metformin and make lifestyle changes — especially exercise — which is the treatment of choice.”

It is interesting that no matter where a medical practitioner ultimately stands on the pharmaceutical side of diabetes care the common denominator in overall health care seems to revert to lifestyle alterations that include watching the foods you eat and working to maintain a healthy weight through exercise. These two approaches can help avert diabetes and can help lessen the effects post-diagnosis.

Legislative Wrangling: Native American Diabetes Program: Native Americans who live with diabetes may want to continue to watch a developing story that works to provide greater funding for research and support through the Special Diabetes Program for Indians (SPDI).

Indian Health Services provides a history of the program, “In response to the diabetes epidemic among American Indians and Alaska Natives, Congress established the Special Diabetes Program for Indians (SDPI) in 1997. The Special Diabetes Program for Indians is currently a $150 million per year grant program that provides funding for diabetes treatment and prevention services at 399 IHS, Tribal, and Urban Indian health programs in all 12 IHS Areas across the United States. Administered by the IHS Division of Diabetes (DDTP), and with guidance from the Tribal Leaders Diabetes Committee (TLDC), the Special Diabetes Program for Indians grant programs use proven, evidence-based, and community-driven diabetes treatment and prevention strategies that address each stage of the disease.”

A recent press release suggests a new push for added funding, “U.S. Senators Susan Collins and Byron Dorgan (D-N.D.) today introduced bipartisan legislation to reauthorize the Special Diabetes Program, a critical public health program that improves diabetes research, treatment and prevention.”

Dorgan said, “Reauthorization of these vital diabetes research programs will help millions of Americans who are suffering from diabetes, particularly in the Native American community, which is dramatically more affected by the disease than other ethnic groups. In addition, given that one of every five health care dollars is spent on treating individuals with diabetes, this program is a smart investment.”

In a time when health care reform is a regular point of discussion this new legislation is intended to capitalize on the health needs of Native Americans and a nod to the improved health of this ethic group.

Collins added, “After more than a decade of investment, the Special Diabetes Program is making tangible improvements in the lives of Americans who are living with diabetes. It is also making significant progress toward a cure. Private organizations like the Juvenile Diabetes Research Foundation and the American Diabetes Association are also doing their part to fund research, support patients and families, and spur the government on to do even more. As a consequence, we have seen some encouraging breakthroughs and the development of better treatments. We are on the threshold of a number of important new discoveries that may ultimately lead to cure. That is why it is critical that Congress extend funding for the Special Diabetes Program.”

The end result of the legislation would actually provide more funding to the SDPI program, “Since its inception in 1997, the Special Diabetes Program has funded significant Type 1 diabetes research as well as treatment initiatives targeted to American Indian and Alaska Native populations. The Dorgan-Collins reauthorization bill would provide each of these programs $200 million per year over the next five years.” The proposed increase amounts to $50 million more per year.

According to the Governmental Indian Affairs website the goal of the program is three-fold…

Community-Directed Diabetes Programs:  …[providing] funds to 333 IHS, Tribal, and Urban Indian health programs in 35 states to begin or enhance local diabetes treatment and prevention programs.

Demonstration Projects:  In 2004, Congress increased Special Diabetes Program for Indians funding to develop and implement projects.

Strengthening the Diabetes Data Infrastructure:  Strengthen[ing] the diabetes data infrastructure of the Indian health system by improving diabetes surveillance and evaluation capabilities and supporting the development and implementation of the IHS Electronic Health Record. (Source: IHS.org)

Reversing Type 1 Diabetes in Mice: New nanovaccine innovations have proven successful in reversing the effects of Type 1 diabetes in mice. Is it possible to take the leap from mice achievement to successful human trials? It might if one researcher has his way.

In the scheme of body dynamics you have an immune system that is incredibly complex. If a disease invades your body then immune cells are sent to do battle with the invaders. Sometimes those immune cells take their job pretty seriously. The body is equipped with a counter balance that allows a second group of cells to try to stop the ‘rogue’ immune cells from the damage they may be doing, but in most cases the immune cells are too strong resulting in the weakening of the secondary cells, and in Type 1 diabetes the death of insulin creating beta cells.

Because Type 1 diabetes is an autoimmune disease it’s as if the immune cells have become something akin to an overbearing parent. They mean well, but stifle so many areas that in the end damage can occur even when the immune system was simply trying to help.

Think of the effect on the mice in this study this way – the immune system detects the beta cells of the pancreas as an intruder. The immune system sends a contingent of cells to ward off what they believe to be invaders. The body responds with a staged intervention by sending troops to stop the immune system from destroying the pancreas. The problem is there are too few ‘troop’ cells and they just aren’t strong enough to battle the immune system.

The theory behind the new vaccine is that if there were more ‘troops’ cells that could stand up to the immune cells they might prevent damage to the beta cells. If successful in humans this could have a very positive effect in other autoimmune diseases like multiple sclerosis and rheumatoid arthritis. In both cases the struggle faced by patients have to do with an overactive immune system that ultimately did damage by being overbearing. The potential of the nanovaccine is to provide a more level playing field in very specific instances.

This is important because you don’t want to completely suppress the immune system, but there may be causes when improving the strength of other cells is an important component in specific disease protection.

The lead researcher in this study is Dr. Pere Santamaria, a professor at the Julia McFarlane Diabetes Research Centre at the University of Calgary in Alberta according to HealthDay, which went on to say, “The body doesn’t just allow the autoimmune aggression to go unchecked. There is a counter-mechanism that produces immune system cells to try to fight the rogue immune cells that are creating the damage in type 1 diabetes.”

Santamaria said, “With this nanovaccine, we engage the weak immune cells and make them multiply and divide, and then they can counter the autoimmune response without impairing systemic immunity.” This essentially is the ‘intervention’ process that helps keep the immune system in check.

How exactly does it work? According to the HealthDay report, “Instead of directly attacking the stronger cells, the autoregulatory T cells turn off the signal that tells the stronger immune cells to attack, effectively stopping the destruction of the beta cells.”

Time will tell if this approach is simply a dead end, a stepping-stone to a differing therapy or the answer science has been seeking in the battle against Type 1 diabetes.

Diabetes: Cellular News: We’ve reported previously that high birth-weight babies are susceptible to diabetes later in life. New research indicates the same may be true for low birth-weight babies although the underlying reasons may be different.

The issue with low birth-weight babies has to do with a duo of gene variants. If an infant has these variants it can lead to both low birth-weight and a greater likelihood of diabetes.

According to BabyChums.com, “The collaborative effort of scientists from Britain, Finland, the Netherlands and the United States has yielded important research which could change the way diabetes is dealt with in the future.”

Researchers analyzed nearly 20 studies covering more than 38,000 European patients. Jim Wilson, a Scotland medical researcher said: “Finding two gene variants that decrease birth-weight is the first exciting step to unraveling the well known associations between birth-weight and killer diseases in later life. It is particularly interesting that one of these variants is also a risk factor for Type 2 diabetes.

“These genes will begin to reveal the biology behind how low birth-weight increases the risk of adult-onset diabetes, heart disease and high blood pressure,” Wilson is quoted by BabyChums.com.

One of these genes is known as Adenylate cyclase type 5 (ADCY5) and, “According to the researchers’ data, people who inherit two copies of this gene in two specific genetic regions have a 25 percent increased chance of developing diabetes later in adulthood,” said Babychums.com.

It seems relevant that certain genetic markers exist that can pose a potential problem for development potential in diabetes.

However, other researchers have cautioned that low birth-weight can be attributed to multiple circumstances and that simply because a new baby may be born with low birth-weight one cannot simply assume that diabetes will always be the outcome.

Meanwhile, Leptin is back in the news. UT Southwestern Medical Center researcher Dr. Joel Elmquist, senior author of a recent study said, “Our findings indicate that [obesity-linked diabetes] is not necessarily the case, at least in mice. We can make the animals very diabetic without obesity, suggesting that there may be a circuit or path of resistance to these signals in the brain that helps explain the powerful anti-diabetic actions of leptin.”

This researcher notes that Type 2 diabetes may not be directly attributable to obesity as he found similar issues in mice that were not obese and yet because they were leptin deprived they struggled with life threatening diabetic symptoms.

Interesting a single shot of leptin caused diabetic mice to reverse course in diabetes. “In the current study,” according to DNAIndia.com, “the researchers genetically engineered mice to lack both leptin and insulin receptors in their POMC neurons. Both receptors remained intact in all other cell types and tissues, including the liver and ovaries.”

What was the result? Well, according to the same report, “The researchers found that when they removed both receptors from these particular neurons the mice displayed systemic insulin resistance and became severely diabetic but not obese. Dr. Elmquist said the findings suggest that leptin and insulin – when acting on these neurons in the brain – are both necessary and can compensate for each other if there’s a shortage of one.”

Elmquist concluded by saying, “There seems to be what I call a functional redundancy in these neurons as it relates to blood sugar regulation. We don’t know if the same neurons respond to both leptin and insulin, but it is clear that functionally leptin can compensate for a lack of insulin and vice versa.”

Charlie Kimball: The Race is On: He started racing go-carts at the age of nine. Today he’s one of the best open wheel racecar drivers who was also nearly sidelined by a diagnosis of diabetes.

Charlie Kimball is a an American of British descent and is considered a rising star in his field. Wikipedia shares his racing career to date…

“Kimball’s single-seater career started in 2002 when he took part in the American Formula Dodge national championship, finishing the season in 10th place overall. He also won three races in the SCCA Formula Ford series. For 2003 he moved up to Formula Ford U.S., finishing third overall.

“In 2004 he competed in the full UK Formula Ford championship for Team JLR, taking two race wins and eleven podiums on his way to fourth in the championship. His performances earned him a drive with front-runners Carlin Motorsport in the 2005 British Formula Three Championship, where he took five race wins to finish an impressive second behind teammate Álvaro Parente.

“For 2006 Kimball stayed in Formula Three, but moved up to the Formula Three Euroseries with the French Signature-Plus team. He took one race win and three podiums to finish the season in eleventh place.

“In 2007 he competed in the Formula Renault 3.5 Series for the Italian Victory Engineering team, alongside Dutchman Giedo van der Garde. He competed in 12 races and finished 24th in points with a best finish of 8th in the Monza and Nurburgring sprint races. His departed the team due to the onset of Type 1 Diabetes, which required hospitalization.”

It was at this point that life changed dramatically for Kimball. He had actually gone to the doctor for a rash and left with a diagnosis of diabetes. Kimball struggled with whether he would even be able to continue with racing.

According to the St. Clair Times, “He’s been able to use that passion to help educate fans about the dangers of diabetes, as well as demonstrate an ability to continue pursuing his dreams.”

Said Kimball, “While it (diabetes) may have been a speed bump, it’s definitely not a roadblock. Don’t get me wrong: I’d give it back if I could. But at the end of the day, I believe I’m a better person for it.

“I’m leading not just a normal life, but kind of an extraordinary life. With all the travel that I do, and the physical and mental aspects of being in a racecar.”

For 2009 Kimball signed to drive in Firestone Indy Lights for the new Team PBIR outfit. He stated that an influencing factor in his return to the U.S. is to increase Diabetes awareness in his home country.

And if you’re wondering how Kimball manages testing while engaged in some serious racing the St. Clair Times provides the tools of his trade, “Kimball has a number of things that set him apart from other drivers, such as a continuous glucose monitor that attaches to his steering wheel and graphs his blood sugar every five minutes so he can keep an eye on his levels while driving, and a special helmet that enables him to sip orange juice if his blood sugar levels drop while racing without lifting a finger.”

Kimball concludes by saying, “With good dietary management, good discipline, good healthcare, it doesn’t have to get in the way. I’m a big advocate of making diabetes work in your life instead of changing for diabetes.”

Reduce Diabetic Risks Through Breastfeeding: The time following the birth of a child brings a beautiful connection between mother and child. For many this has meant breastfeeding their child for at least six months. Others have moved toward a formula feeding that may be necessary and unavoidable. However, research now points to some very specific reasons to breastfeed your new baby if at all possible.

The data available today indicates that nearly 1,000 infants in the United States can be saved each year if mothers would breastfeed their babies. Research also indicates that billions of dollars in health care costs could be saved if breastfeeding once again became the norm.

Two diseases that often go together are Type 2 diabetes and asthma. Research indicates that if a child is breastfeed they are much less likely to contract either condition. However, the good news can extend to the mother as well. The research further indicates that when a mother breastfeeds her child she becomes less likely to develop Type 2 diabetes.

Oreon.gov provides the following comprehensive list of benefits related to breastfeeding…

• Immediate Health Benefits for Breastfed Babies
• Long-term Health Benefits for Breastfed Babies
• Less childhood obesity
• Reduced risk of some chronic diseases that develop during childhood including: juvenile diabetes, childhood cancers, and allergic disease/asthma
• Enhanced neurological development that may result in higher IQs and better eyesight
• Suckling at the breast promotes good jaw development and encourages the growth of straight, healthy teeth
• Immediate Health Benefits for a Mother who Breastfeeds
• Uterus returns to normal size more quickly and mother has reduced blood loss
• Exclusive breastfeeding delays the return of fertility in most women
• Reduced insulin needs in diabetic mothers
• Psychological benefits of increased self-confidence and enhanced bonding with infant
• Helps mother get needed rest by requiring that she sit or lie down with baby every few hours to feed
• Long-term Health Benefits for a Mother who Breastfeeds
• Earlier return to pre-pregnancy weight, with no return of weight once weaning occurs
• Reduced risk of breast, ovarian, and endometrial cancers
• Reduced risk of osteoporosis and bone fracture
• Social and Economic Benefits for Breastfeeding Families, Employers and Health Systems
• Family savings of several hundred dollars when the cost of breastfeeding is compared to the cost of using artificial formula

Healthcare reform reinforces this idea by insisting that large businesses be required to provide a private space for new mothers to express milk for their infants. The reason this has become such an important element to healthcare is that many mothers are either the sole breadwinner for their families or are huge contributors to the financial needs their families face. If there are health benefits to providing their child with breast milk then it just makes sense to offer a comfortable and private space for them to provide the milk their child needs for both nourishment and to fend off potential disease later in life.